Cited by 268Cannabis and Cannabinoid ResearchAcne and Rosacea Treatments and EffectsDermatology and Skin Diseases

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes

Open access

Abstract

The endocannabinoid system (ECS) regulates multiple physiological processes, including cutaneous cell growth and differentiation. Here, we explored the effects of the major nonpsychotropic phytocannabinoid of Cannabis sativa, (-)-cannabidiol (CBD), on human sebaceous gland function and determined that CBD behaves as a highly effective sebostatic agent. Administration of CBD to cultured human sebocytes and human skin organ culture inhibited the lipogenic actions of various compounds, including arachidonic acid and a combination of linoleic acid and testosterone, and suppressed sebocyte proliferation via the activation of transient receptor potential vanilloid-4 (TRPV4) ion channels. Activation of TRPV4 interfered with the prolipogenic ERK1/2 MAPK pathway and resulted in the downregulation of nuclear receptor interacting protein-1 (NRIP1), which influences glucose and lipid metabolism, thereby inhibiting sebocyte lipogenesis. CBD also exerted complex antiinflammatory actions that were coupled to A2a adenosine receptor-dependent upregulation of tribbles homolog 3 (TRIB3) and inhibition of the NF-κB signaling. Collectively, our findings suggest that, due to the combined lipostatic, antiproliferative, and antiinflammatory effects, CBD has potential as a promising therapeutic agent for the treatment of acne vulgaris.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci64628

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 79 references

Cited by

Sorted by citations

Metadata

Authors
Oláh, A., Tóth, B. I., Borbíró, I., Sugawara, K., Szöllõsi, A. G., Czifra, G., Pál, B., Ambrus, L., Kloepper, J., Camera, E., Ludovici, M., Picardo, M., Voets, T., Zouboulis, C. C., Paus, R., & Bíró, T.
Affiliations
  • University of Debrecen (HU)
  • Osaka City University (JP)
  • University of Lübeck (DE)
  • San Gallicano Hospital (IT)
  • KU Leuven (BE)
  • Städtisches Klinikum Dessau (DE)
  • University of Manchester (GB)
Venue
Journal of Clinical Investigation
Published
2014-07-25
Volume
124
Issue
9
Pages
3713-3724
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2096513953
Cited by
268
References
79
Citations by year
2026: 12 · 2025: 22 · 2024: 27 · 2023: 33 · 2022: 32 · 2021: 34 · 2020: 31 · 2019: 20 · 2018: 19 · 2017: 15 · 2016: 12 · 2015: 6 · 2014: 4
FWCI
8.99
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion)
Funders
  • Australian Government
  • European Commission (FP7-REGPOT-2008-1, 330489, 229920, IUAP P7/13)
  • Ministero della Salute (RF 2010)
  • Hungarian Scientific Research Fund (101761, 105369)
  • KU Leuven (P7/13)
  • Vlaamse regering
  • FP7 Research Potential of Convergence Regions (2008-1)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Keywords
cannabidiol, sebocytes, lipogenesis, TRPV4, MAPK/ERK pathway, NRIP1, adenosine A2A receptor, TRIB3, NF-κB signaling, endocannabinoid system, acne, arachidonic acid, linoleic acid, testosterone
MeSH terms
Acne Vulgaris, Anti-Inflammatory Agents, Cannabidiol, Humans, Sebaceous Glands, Sebum, Extracellular Signal-Regulated MAP Kinases, Lipogenesis, TRPV Cation Channels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review